Kangstem Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	252,065	218,206	113,229	133,971	109,830	124,057
Market Cap Growth	124.28%	92.71%	-15.48%	21.98%	-11.47%	-36.85%
Enterprise Value	228,861	199,995	95,018	129,761	85,183	115,828
Last Close Price	2680.00	2320.00	1689.51	2003.15	2103.33	2375.78
PS Ratio	73.64	61.08	14.62	10.55	6.74	10.00
PB Ratio	4.05	3.16	2.62	2.67	2.08	1.74
P/TBV Ratio	5.52	4.18	2.68	2.82	2.27	1.85
EV/Sales Ratio	66.86	55.98	12.27	10.21	5.23	9.34
Debt / Equity Ratio	0.15	0.14	0.20	0.27	0.25	0.20
Net Debt / Equity Ratio	-0.37	-0.42	-0.23	-0.47	-0.44	-0.60
Net Debt / EBITDA Ratio	1.52	1.91	0.85	1.26	1.40	2.26
Net Debt / FCF Ratio	1.51	2.36	0.50	1.33	1.19	1.97
Asset Turnover	-	0.05	0.11	0.16	0.18	0.13
Inventory Turnover	-	3.26	4.76	21.16	18.57	17.37
Quick Ratio	4.12	4.75	2.92	2.07	2.73	3.38
Current Ratio	4.56	5.25	3.69	2.55	3.22	3.80
Return on Equity (ROE)	-19.21%	-18.65%	-15.18%	-45.17%	-32.55%	-36.40%
Return on Assets (ROA)	-	-16.06%	-13.52%	-17.59%	-13.99%	-15.31%
Return on Capital Employed (ROCE)	-26.40%	-24.10%	-30.80%	-36.40%	-31.00%	-26.40%
Earnings Yield	-4.02%	-4.80%	-6.77%	-16.38%	-18.43%	-17.21%
FCF Yield	-6.11%	-5.65%	-17.29%	-13.35%	-17.82%	-17.43%
Buyback Yield / Dilution	-59.56%	-23.21%	-38.90%	-7.02%	-36.23%	-24.89%